帕布昔利布杂质23571188-82-4 新品

中文名称帕布昔利布杂质23中文同义词4-[6-[(6-溴-8-环戊基-7,8-二氢-5-甲基-7-氧代吡啶并[2,3-D]嘧啶-2-基)氨基]-3-吡啶基]-1-哌嗪羧酸叔丁酯;4-[6-[(6-溴-8-环戊基-7,8-二氢-5-甲基-7-氧代吡啶并[2,3-D]嘧啶-2-基)氨基]-3-吡啶;帕布昔利布中间体1;4-[6-[(6-溴-8-环戊基-7,8-二氢-5-甲基-7-氧代吡啶并[2,3-D]嘧啶-2-基)氨基]-3-吡啶基]-1-哌嗪羧酸叔丁酯哌泊塞克雷布中间体1KG;4-[6-(6-溴-8-环戊基-5-甲基-7-氧代-7,8-二氢吡啶并[2,3-D]嘧啶-2-基氨基)-吡啶-3-基]-哌嗪-1-羧酸叔丁酯;帕布昔利布中间体6;(3E)-1-(2-氯乙酰基)-2,3-二氢-3-(甲氧基苯基亚甲基)-2-氧代-1H-吲哚-6-羧酸甲酯;帕布昔利布中间体一英文名称tert-Butyl4-(6-(6-bromo-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydro-pyrido(2,3-d)pyrimidin-2-ylamino)-pyridin-3-yl)-piperazine-1-carboxylate英文同义词4-[6-(6-BROMO-8-CYCLOPENTYL-5-METHYL-7-OXO-7,8-DIHYDRO-PYRIDO[2,3-D]PYRIMIDIN-2-YLAMINO)-PYRIDIN-3-YL]-PIPERAZINE-1-CARBOXYLICACIDTERT-BUTYLESTER;tert-butyl4-(6-((6-broMo-8-cyclopentyl-5-Methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyriMidin-2-yl)aMino)pyridin-3-yl)piperazine-1-carboxylate;1-Piperazinecarboxylicacid,4-[6-[(6-broMo-8-cyclopentyl-7,8-dihydro-5-Methyl-7-oxopyrido[2,3-d]pyriMidin-2-yl)aMino]-3-pyridinyl]-,1,1-diMethylethylester;4-[6-[(6-Bromo-8-cyclopentyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinecarboxylicacid1,1-dimethylethylester;4-[6-(6-bromo-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidin-2-ylamino)-pyridine3-yl]-piperazine-1-carboxylicacidtert-butylester;tert-butyl4-{6-[(6-bromo-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino]pyridin-3-yl}piperazine-1-carboxylat;tert-butyl4-[6-[(6-bromo-8-cyclopentyl-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]pyridin-3-yl]piperazine-1-carboxylate;tert-Butyl4-(6-((6-bromo-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)CAS号571188-82-4分子式C27H34BrN7O3分子量584.51EINECS号1592732-453-0相关类别医药中间体;帕布昔利布中间体;帕博西尼中间体;帕博西布中间体;对照品-杂质对照品;杂质对照品;日用化学品;科研精品试剂;Anticancer;Palbociclib;PD0332991Mol文件MolFile结构式帕布昔利布杂质23性质熔点>250℃沸点720.0±70.0°C(Predicted)密度1.439±0.06g/cm3(Predicted)储存条件2-8°C(protectfromlight)酸度系数(pKa)5.24±0.10(Predicted)外观浅黄色至黄色固体InChIKeyUTSOLZWQDXJQRH-UHFFFAOYSA-NSMILESN1(C(OC(C)(C)C)=O)CCN(C2=CC=C(NC3=NC=C4C(C)=C(Br)C(=O)N(C5CCCC5)C4=N3)N=C2)CC1帕布昔利布杂质23用途与合成方法用途帕布昔利布杂质23是帕布昔利的杂质，是辉瑞公司开发的治疗乳腺癌的实验药物。它是细胞周期素依赖性激酶CDK4和CDK6的选择性抑制剂。此外，它衍生自6-溴-2-氯-8-环戊基-5-甲基吡啶-[2,3-d]嘧啶-7（8H）-酮,用于制备吡啶基[2,3-d]嘧啶-7（8H）-酮衍生物，作为CDK4和/或用于治疗疾病的CDK6抑制剂。安全信息MSDS信息帕布昔利布杂质23上下游产品信息"帕布昔利布杂质23"相关产品信息